Results 181 to 190 of about 191,032 (247)

Current Advancements of Probiotic Foods and Their Role in Sustainable Food Security

Food Bioengineering, EarlyView.
ABSTRACT Probiotic foods have evolved from traditional fermented products to scientifically validated functional foods, defined by the FAO and WHO as live microorganism that confer a health benefit on the host when administered in adequate amounts, with effects being strain, does and end point specific.
Ashenafi Teklay Yaekob, Gebremedhin Gebreslassie, Etsay Mesele, Tesfakiros Semere   +3 more
wiley   +1 more source

Oral vaccination with inhibin DNA vaccine for promoting spermatogenesis in rats. [PDF]

Anim Reprod
Meng J, Feng J, Xiao L, Hu N, Lan X, Wang S.   +5 more
europepmc   +1 more source

Pandemic Im/mobilities, reproductive injustices, and assisted reproductive technology use among Taiwanese LGBTQ parents

Feminist Anthropology, EarlyView.
Abstract This article examines how mobility restrictions imposed by governments during the COVID‐19 pandemic intensified reproductive and mobility injustices. It traces shifting configurations of privilege and inequality within marginalized groups whose reproductive desires remain legally and socially unrecognized.
Sara L. Friedman
wiley   +1 more source

CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery. [PDF]

Vaccines (Basel)
Liu G, Yuan Z, Wu Z, Yang Q, Ding T, Yu K, Dong J.   +6 more
europepmc   +1 more source

T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD). [PDF]

Viruses
Aps LRMM, Venceslau-Carvalho AA, Freitas CL, Porchia BFMM, Silva MO, Pereira LR, Sales NS, Pelegrin GF, Segabinazi E, Rodrigues KB, Silva JRD, Almeida BDS, Farias JP, Castro-Amarante MF, Minoprio PMC, Ferreira LCS, Dos Santos Alves RP.   +16 more
europepmc   +1 more source

MIP-3α-antigen fusion DNA vaccine enhances sex differences in tuberculosis model and alters dendritic cell activity early post vaccination. [PDF]

Sci Rep
Gordy JT, Bates RE, Glass E, Meza J, Li Y, Schill C, Taylor AD, Wang T, Chen F, Plunkett K, Karanika S, Karakousis PC, Markham RB.   +12 more
europepmc   +1 more source

Global research hotspots and trends in DNA vaccine research: A bibliometric and visualization study from 2014 to 2024. [PDF]

Hum Vaccin Immunother
Zhang J, Zhang H, Yao C, Gu L, Dong S, Wu Y, Miao L.   +6 more
europepmc   +1 more source

Cost‐effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV‐positive women in cervical cancer screening

International Journal of Cancer, EarlyView.
What's New? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon, Johannes A. Bogaards, Johannes Berkhof   +2 more
wiley   +1 more source

Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production. [PDF]

Sci Rep
Gül A, Erkunt Alak S, Can H, Karakavuk M, Korukluoğlu G, Altaş AB, Gül C, Karakavuk T, Köseoğlu AE, Ülbeği Polat H, Yazıcı Malkoçoğlu H, Taş Ekiz A, Abacı İ, Aksoy Ö, Enül H, Adıay C, Uzar S, Saraç F, Ün C, Gürüz AY, Kantarcı AG, Akbaba H, Erel Akbaba G, Yılmaz H, Değirmenci Döşkaya A, Taşbakan M, Pullukçu H, Karasulu E, Tekin Ş, Döşkaya M.   +29 more
europepmc   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, EarlyView.
What's New? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source